Literature DB >> 6427223

Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation.

E Rinderknecht, B H O'Connor, H Rodriguez.   

Abstract

Fresh human peripheral blood lymphocytes were induced with desacetylthymosin -alpha 1 and staphylococcal enterotoxin B. The induced gamma interferon (or IFN-gamma, immune interferon, type II interferon) was purified to homogeneity utilizing controlled-pore glass, concanavalin A-Sepharose, Bio-Gel P100, or Sephacryl S-200, and reversed phase high performance liquid chromatography. This procedure resulted in two active species with apparent Mr = 20,000 and 25,000 as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Both species were found to have identical amino acid sequences with a pyroglutamate residue as NH2-terminus. In both cases six different COOH termini were found. They are, at least qualitatively, identical in both species. There are two possible Asn-X-Ser/Thr glycosylation sites. Both carry carbohydrates in the Mr = 25,000 species whereas in the Mr = 20,000 species only one site is glycosylated. This likely explains the difference in apparent molecular weight between the two species and the expected molecular weight based upon the amino acid sequence.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6427223

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.

Authors:  S S Tabibzadeh; M A Gerber; P G Satyaswaroop
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

2.  The effect of benzyl alcohol on recombinant human interferon-gamma.

Authors:  X M Lam; T W Patapoff; T H Nguyen
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

3.  Crystallization and preliminary X-ray analysis of a 1:1 complex between a designed monomeric interferon-gamma and its soluble receptor.

Authors:  M Randal; A A Kossiakoff
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

Review 4.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  Interaction of truncated human interferon gamma variants with the interferon gamma receptor: crucial importance of Arg-129.

Authors:  J Haelewyn; L Michiels; P Verhaert; M F Hoylaerts; R Witters; M De Ley
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

6.  PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice.

Authors:  Christine M Fam; Stephen P Eisenberg; Sharon J Carlson; Elizabeth A Chlipala; George N Cox; Mary S Rosendahl
Journal:  J Interferon Cytokine Res       Date:  2014-05-19       Impact factor: 2.607

7.  Identification of a human non-interferon lymphokine activating monocyte complement biosynthesis.

Authors:  C Drouet; A Reboul; M Colomb
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

8.  Source of heterogeneity in secreted interferon-gamma. A study on products of translation in vitro.

Authors:  N J Bulleid; E Curling; R B Freedman; N Jenkins
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

9.  Human interferon-gamma has three domains associated with its antiviral function: a neutralizing epitope typing scheme for human interferon-gamma.

Authors:  A Y Kwok; X Zu; C Yang; M J Alfa; F T Jay
Journal:  Immunology       Date:  1993-05       Impact factor: 7.397

10.  Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.

Authors:  T W Chang; S McKinney; V Liu; P C Kung; J Vilcek; J Le
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.